BUKO Pharma-Kamapgne

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 11 Apr 2016
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

9,999€

Financial year: Jan 2014 - Dec 2014

Lobbyists (Full time equivalent)

4.75 Fte (7)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    BUKO Pharma-Kamapgne   (BUKO)

    EU Transparency Register

    88556632719-16 First registered on 07 Dec 2009

    Goals / Remit

    - Unabhängige VerbraucherInnenwerbung
    - Menschenrecht auf Gesundheit
    - Rationaler Arzneimittelgebrauch
    - Zugang zu unentbehrlichen Medikamenten

    Main EU files targeted

    Arzneimittelforschungspolitik
    GAVI

    Address

    Head Office
    August-Bebel-Str. 62
    Bielefeld 33602
    GERMANY
  • People

    Total lobbyists declared

    7

    Employment timeLobbyists
    100%2
    75%2
    50%2
    25%1

    Lobbyists (Full time equivalent)

    4.75

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Ms Hedwig Diekwisch (Geschäftsführerin)

    Person with legal responsibility

    Ms Hedwig Diekwisch (Geschäftsführerin)

  • Categories

    Category

    III - Non-governmental organisations

    Subcategory

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    HAI
    BUKO
    ISDB
    Aktionsbündnis gegen Aids
    PHM

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2014 - Dec 2014

    Lobbying costs for closed financial year

    9,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    Wissenschaftliche Recherche zu Arzneimittelversorgung und Arzneimittelforschung sowie Publikation der Ergebnisse mittels zahlreicher Medien, Vorträgen und Straßentheateraufführungen

    Other activities

    Zugang zu ART, TB-Medikamenten
    Forschung und Entwicklung
    VerbraucherInnenschutz
    Rationale Arzneimittelprolitik
    Werbeverbot für rezeptpflichtige Medikamente

  • Meetings

    Meetings

    None declared

Download this datacard